Fundraising Fox

Kurt von Emster

Investor

Managing Partner at Abingworth

Menlo Park, California

Writes $15M – $30M checks Β· typically $22.5M

About

Kurt von Emster joined Abingworth in January 2015 and has over 30 years of experience investing in private and public life science companies. He previously worked as a biotechnology and healthcare analyst and portfolio manager at Franklin Templeton, was a General Partner at MPM Capital, and in 2009 co-founded the US healthcare investment firm venBio, where he was most recently a Partner. He holds a Bachelor of Arts in Business and Economics.

Invests in

Biotech

Experience

  1. AbingworthManaging Partner, Head of Life Sciencescurrent2015 β€” presentMenlo Park, CA
  2. Iambic TherapeuticsBoard Membercurrent2023 β€” presentSan Diego, California, United States
  3. Tizona Therapeutics, Inc.Board Membercurrent2020 β€” presentSouth San Francisco, California, United States
  4. Orbus TherapeuticsBoard Membercurrent2020 β€” presentPalo Alto, California, United States
  5. SFJ Pharmaceuticals, Inc.Board Membercurrent2020 β€” presentPleasanton, California, United States
  6. Jasper TherapeuticsBoard Membercurrent2019 β€” presentRedwood City, California, United States
  7. CymaBay TherapeuticsBoard of Directors2009 β€” 2024Newark, California, United States
  8. VaxcyteChairman2015 β€” 2022San Carlos, California, United States
  9. Vera Therapeutics, Inc.Chairman2020 β€” 2022South San Francisco, California, United States
  10. Trishula Therapeutics, Inc.Board Member2020 β€” 2022South San Francisco, California, United States
  11. CRISPR TherapeuticsMember Board of Directors2015 β€” 2019Cambridge, MA
  12. Kesios TherapeuticsBoard Member2015 β€” 2017London Area, United Kingdom
  13. Cytos BiotechnologyBoard Member2012 β€” 2015Zurich Switzerland
  14. Aurinia PharmaceuticalsBoard Member2014 β€” 2015Victoria, BC
  15. venBio LLCFounding Partner2009 β€” 2015
  16. Somaxon PharmaceuticalsBoard of Directors2005 β€” 2013San Diego County, California, United States
  17. Facet BiotechBoard of Directors2009 β€” 2010
  18. MPM CapitalGeneral Partner / Portfolio Manager2000 β€” 2009
  19. Franklin Templeton InvestmentsVice President - Portfolio Management1989 β€” 2000

Education

  1. UC Santa BarbaraBachelor of Science (BS), Business and Economics1985 β€” 1989

Skills & more

Biotechnology28Lifesciences10Venture Capital55Investments20Pharmaceutical Industry11Corporate Development11Strategy28Start-ups10Mergers & Acquisitions13Strategic Planning4Investor Relations4Oncology2
+12 moreEntrepreneurshipCompetitive AnalysisBusiness PlanningPrivate EquityTechnology TransferManagementCommercializationLicensingExecutive ManagementCross-functional Team LeadershipM&A experienceValuation
  • CFA

From Kurt's professional profile.

Same school

Shared employers

Deals Β· 3

Iambic Therapeutics, Inc.Board seat

via Abingworth Β· filed Oct 2023 Β· $110M raise

Vera TherapeuticsBoard seat

via Abingworth Β· filed Feb 2021 Β· $70.7M raise

SutroVaxBoard seat

via Abingworth Β· filed Mar 2017 Β· $60.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Abingworth